Replies to post #116307 on OWC Pharmaceutical Research Corp (OWCP)

[surfgreen]

Zynerba does for Fragile X but Myeloma is much more prevalent.

[Dick Hoolihan]

According to an earlier post, the multiple myeloma patent application was rejected -- unpatentable because it infringed on other patents. So you have to convince me that post is wrong or your post is meaningless.

[gruber72]

This is the most recent Int'l Patent info that I could find, on WIPO.com.

It shows no rejection on the current status. I-Glow, the onus is on you to show me documentation of where this has been rejected. Not OLD applications, but this CURRENT application. If you can't, then your already thin credibility is at risk.


https://patentscope.wipo.int/search//iasr?ia=IL2016050608&PAGE=PDF&ACCESS=screen&TOK=kphxfWdhmvZ1OSO16ofUTJinFIU